Abstract
Chronic subthalamic nucleus deep brain stimulation (STN-DBS) is an efficacious treatment for idiopathic Parkinson's disease (PD) that cannot be further improved by medical therapy. We present a case of an individual with juvenile parkinsonism caused by homozygous deletion of exon 3 in the parkin gene with disabling long-term side-effects from levodopa who underwent bilateral STN neuromodulation. Parkin-linked parkinsonism may show clinical features different from sporadic PD, yet it shares levodopa responsiveness. Because levodopa responsiveness is a predictor of STN-DBS efficacy, we argued that this kind of surgical approach might be efficacious in hereditary parkin-linked juvenile parkinsonism. We evaluated clinical and functional assessment before and 12 months after surgery. The results showed that the Unified Parkinson Disease Rating Scales Motor score improved by 84% in our patient, the levodopa equivalent daily dose medication (LEDD) was reduced by 66%, and, finally, disabling and severe dyskinesias disappeared.
References
Sep 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·P LimousinA L Benabid
Dec 16, 1998·Annals of Neurology·N HattoriY Mizuno
May 13, 1999·The New England Journal of Medicine·B P BejjaniY Agid
Aug 6, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·G L DeferM Levivier
Jul 25, 2000·Journal of Neural Transmission·M M PinterH Binder
Sep 14, 2000·Brain & Development·Y YamamuraY Mizuno
Sep 29, 2001·The New England Journal of Medicine·UNKNOWN Deep-Brain Stimulation for Parkinson's Disease Study GroupA E Lang
Mar 2, 2002·Brain : a Journal of Neurology·M L WelterY Agid
May 15, 2002·Stereotactic and Functional Neurosurgery·X LiuT Aziz
May 30, 2002·Neurology·L M A RomitoA Albanese
Sep 26, 2002·Neurology·P D CharlesP Pollak
Dec 25, 2002·Neurology·E LagrangeP Pollak
Citations
Sep 26, 2013·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Hee Jin KimBeom S Jeon
Sep 13, 2007·The Neurologist·Drew S Kern, Rajeev Kumar
May 18, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·M CapecciM G Ceravolo
May 7, 2010·CNS Drugs·Teri R Thomsen, Robert L Rodnitzky
Jan 2, 2010·Neurosurgical Focus·Georgia XiromerisiouGeorgios M Hadjigeorgiou
Dec 11, 2007·Neuroscience Letters·Hao DengJoseph Jankovic
Jan 30, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Ebba LohmannUNKNOWN French Parkinson's Disease Genetics study group
Jun 16, 2010·Acta Neurologica Scandinavica·K K JohansenJ O Aasly
May 23, 2008·Neurosurgery·Juan C Gómez-EstebanJesús Garibi
Jul 1, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Anthony E LangValerie Voon
Nov 3, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Michael SchüpbachAlexis Brice
Nov 11, 2005·Current Opinion in Neurology·Alim Louis BenabidEric Seigneuret
Sep 12, 2019·NPJ Parkinson's Disease·Johanne LigaardLasse Pihlstrøm
Jan 20, 2019·Journal of Neurology·Tomi KuusimäkiValtteri Kaasinen
Jul 10, 2019·Movement Disorders Clinical Practice·Lais Machado de OliveiraRubens Gisbert Cury